King said the Food and Drug Administration claims GlaxoSmithKline ignored the risk of the drug and thousands of people sued the company for failing to inform people of problems associated with the drug.

King said recently the FDA had backed off some of those claims saying the side effects are not as severe as once thought.

A call was placed to GlaxoSmithKline for comment, but has not been returned.